Clinical Study on Bronchial asthma.

The Efficacy of Homoeopathic Simillimum in treating Atopic Bronchial Asthma With an Evaluation based on Serum IgE.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042522

Enrollment

Registered

2022-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Homoeopathic Medicine: Homoeopathic Medicines are selected on basis of Symptom similarity The Dose is selected based upon individualization and susceptibility of the patient The Medicin

Eligibility

Inclusion criteria

Inclusion criteria: Patient selected from age 5 to 60 and patients with clinical presentation of Bronchial asthma and Patients with strong family history and previous atopic History

Exclusion criteria

Exclusion criteria: Patients suffering from other respiratory diseases Patients suffering from other systemic diseases

Design outcomes

Primary

Measure	Time frame
Serum IgETimepoint: after 6 months	—

Secondary

Measure	Time frame
It is expected that the proposed study will be useful in reducing the symptoms of Bronchial asthma and to improve the quality of life of the patients.Timepoint: After 6 months	—

Countries

India

Contacts

Public ContactDr E Nisha Paul

Vinayaka Mission Homoeopathic Medical College and Hospital

Nisha.gopal2012@gmail.com9995680275

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026